New Microbiome Manufacturing Facility in Fishers

Date Published11/27/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name List Biotherapeutics, Inc.,
Parent companyGenome & Company,
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):210
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2023
Domestically, the work will be done:In-house
Capital investment ($):125
Country(ies) from which reshored:Korea, Republic of
City reshored to:Fishers
State(s) reshored to:IN
If relevant, work nearshored to:-
Product(s) reshoredBiotherapeutic products
Find Reshoring Articles